- Safety and Efficacy of a Monoclonal Antibody (CIS43LS) against Malaria in Mali. CIS43LS was protective against P. falciparum infection over a 6-month malaria season in Mali without evident safety concerns https://www.nejm.org/doi/full/10.1056/NEJMoa2206966 2 comments science
Linking pages
Related searches:
Search whole site: site:www.nejm.org
Search title: Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali | NEJM
See how to search.